Aclarubicin in advanced thyroid cancer: a phase II study.

[1]  H. Biersack,et al.  [On the treatment of carcinoma of the thyroid (author's transl)]. , 2008, Deutsche medizinische Wochenschrift.

[2]  D. Schoenfeld,et al.  A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma , 1985, Cancer.

[3]  F. Raue.  Therapie des medullären Schilddrüsenkarzinoms , 1985 .

[4]  E. Thiel,et al.  Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias. , 1985, European journal of cancer & clinical oncology.

[5]  N. Nissen,et al.  Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial , 1984, Cancer treatment reports.

[6]  P M Fayers,et al.  Measuring and analysing quality of life in cancer clinical trials: a review. , 1983, Statistics in medicine.

[7]  R. Bukowski,et al.  Combination chemotherapy of metastatic thyroid cancer. Phase II study. , 1983, American journal of clinical oncology.

[8]  G. Benker,et al.  Ergebnisse der Chemotherapie des Schilddrüsenkarzinoms* , 1983 .

[9]  J. Ebke,et al.  [Combined doxorubicin and bleomycin treatment of metastasising thyroid carcinoma: results in 21 patients (author's transl)]. , 1977, Deutsche medizinische Wochenschrift.

[10]  L. Einhorn,et al.  Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial. , 1986, Cancer treatment reports.

[11]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[12]  R. Catane,et al.  Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid gland. , 1981, Cancer clinical trials.